查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
北美新生儿筛检市场预测至 2030 年 - 区域分析 - 按产品类型（试剂和检测试剂盒及仪器）、技术、测试类型和最终用户（医院和诊所以及诊断实验室）
市场调查报告书
商品编码
1463686

北美新生儿筛检市场预测至 2030 年 - 区域分析 - 按产品类型（试剂和检测试剂盒及仪器）、技术、测试类型和最终用户（医院和诊所以及诊断实验室）

North America Newborn Screening Market Forecast to 2030 - Regional Analysis - by Product Type (Reagents and Assay Kits, and Instruments), Technology, Test Type, and End User (Hospitals and Clinics, and Diagnostic Laboratories)
出版日期: | 出版商: The Insight Partners | 英文 94 Pages | 订单完成后即时交付

价格

2022年北美新生儿筛检市场价值为5.2155亿美元，预计到2030年将达到10.823亿美元；预计2022年至2030年CAGR为9.6%。

政府对新生儿筛检的资金激增推动了北美新生儿筛检市场

各国政府越来越多地为新生儿筛检计画分配资金。这些计划有助于降低儿童及其父母的长期医疗费用，因为先天性和遗传性疾病如果未被发现，可能会导致严重的健康併发症和广泛的医疗干预。透过识别和解决婴儿期的健康问题，政府可以增强公民的健康和福祉。因此，新生儿筛检符合更广泛的公共卫生目标，以改善整体人口健康并减轻医疗保健系统的负担。

政府资助促进了医疗保健取得的公平性，确保所有人都能获得新生儿筛检服务，无论社会经济地位如何。这种包容性对于早期疾病检测和介入至关重要，因为它可以防止不同人口群体之间医疗保健结果的差异。随着各国政府继续透过增加资金和政策支援来优先考虑新生儿筛检，全球新生儿筛检市场一直在经历永续成长。

北美新生儿筛检市场概况

近年来，北美新生儿筛检市场经历了显着成长。随着父母和医疗保健专业人员对早期筛检对于识别和管理先天性疾病重要性的认识不断提高，对新生儿筛检服务的需求显着增加。此外，医疗技术的进步对于增强新生儿筛检能力至关重要——实验室的自动化提高了筛检的准确性、速度和成本效益。这使得医疗专业人员能够提供全面的新生儿筛检，涵盖更广泛的遗传和代谢疾病。有利的立法和监管措施也有利于北美的新生儿筛检市场。许多州和省已经实施了强制性新生儿筛检计划，确保所有婴儿在出生后不久就接受筛检。例如，美国每个州都将新生儿筛检作为公共卫生计划；每年，约有 400 万名婴儿根据该计划接受筛检，检查是否患有分娩时不常出现的疾病。德州卫生与公共服务部于 2021 年 6 月开始对新生儿进行脊髓性肌肉萎缩症 (SMA) 筛检。

遗传异常和先天性问题盛行率的上升凸显了新生儿筛检的重要性。美国国立卫生研究院向布法罗大学的一名研究人员提供了极具竞争力的R01 资助，以领导一项国际项目，该项目旨在显着提高新生儿筛检三种罕见且经常致命的遗传疾病的准确性。此外，美国国立卫生研究院 (NIH) 尤尼斯·甘乃迪·施赖弗国家儿童健康与人类发展研究所还资助了 380 万美元的五年奖金。因此，随着意识的提高、技术的进步、支持性政策和先天性疾病盛行率的增加，北美的新生儿筛检市场正在不断成长。

北美新生儿筛检市场收入及 2030 年预测（百万美元）

北美新生儿筛检市场细分

北美新生儿筛检市场根据产品类型、技术、测试类型、最终用户和国家进行细分。

根据产品类型，北美新生儿筛检市场分为试剂、检测试剂盒和仪器。到 2022 年，试剂和检测试剂盒细分市场将占据更大的北美新生儿筛检市场份额。仪器部分细分为新生儿疾病筛检仪器、脉搏血氧仪、新生儿听力筛检仪器和其他仪器。

从技术面来看，北美新生儿筛检市场分为串联质谱（TMS）、分子检测、免疫检测和酵素检测、脉搏血氧饱和度筛检技术等技术。 2022 年，脉搏血氧仪筛检技术领域占据北美新生儿筛检市场最大份额。

根据测试类型，北美新生儿筛检市场分为干血斑测试、听力筛检测试、危重先天性心臟病（CCHD）测试和其他测试类型。 2022 年，干血斑检测领域占据北美新生儿筛检市场最大份额。

依最终用户划分，北美新生儿筛检市场分为医院、诊所和诊断实验室。到 2022 年，医院和诊所细分市场将占据更大的北美新生儿筛检市场。

按国家/地区划分，北美新生儿筛检市场分为美国、加拿大和墨西哥。 2022年，美国在北美新生儿筛检市场占据主导地位。

Baebies Inc、Bio-Rad Laboratories Inc、Masimo Corp、Medtronic Plc、Natus Medical Inc、PerkinElmer Inc 和 Waters Corp 是北美新生儿筛检市场的一些领先公司。

目录

表中的内容

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：北美新生儿筛检市场 - 主要产业动态

  • 主要市场驱动因素
    • 政府为新生儿筛检提供的资金激增
    • 先天性疾病负担不断增加
    • 新生儿疾病盛行率不断增加
  • 主要市场限制
    • 新生儿筛检政策和实践缺乏统一
  • 主要市场机会
    • 新生儿基因筛检
  • 未来的趋势
    • 机器学习和人工智慧在筛检中的整合
  • 影响分析：

第 5 章：新生儿筛检市场 - 北美市场分析

  • 北美新生儿筛检市场收入，2022 - 2030

第 6 章：北美新生儿筛检市场 - 2030 年收入和预测 - 按产品类型

  • 概述
  • 2022 年和 2030 年北美新生儿筛检市场收入份额（按产品类型划分）
  • 试剂和检测试剂盒
  • 仪器

第 7 章：北美新生儿筛检市场 - 收入和 2030 年预测 - 按技术分类

  • 概述
  • 2022 年和 2030 年北美新生儿筛检市场收入份额（按技术划分）
  • 串联质谱 (TMS)
  • 分子检测
  • 免疫测定和酵素测定
  • 脉搏血氧筛检技术
  • 其他技术

第 8 章：北美新生儿筛检市场 - 2030 年收入和预测 - 按测试类型

  • 概述
  • 2022 年和 2030 年北美新生儿筛检市场收入份额，按测试类型划分 (%)
  • 干血斑测试
  • 听力筛检测试
  • 严重先天性心臟病 (CCHD) 测试
  • 其他测试类型

第 9 章：北美新生儿筛检市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年北美新生儿筛检市场收入份额（按最终用户划分）（%）
  • 医院和诊所
  • 诊断实验室

第 10 章：北美新生儿筛检市场 - 国家分析

  • 我们
  • 加拿大
  • 墨西哥

第 11 章：北美新生儿筛检市场-产业格局

  • 概述
  • 新生儿筛检市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • PerkinElmer Inc
  • Waters Corp
  • Bio-Rad Laboratories Inc
  • Masimo Corp
  • Natus Medical Inc.
  • Baebies Inc
  • Medtronic Plc

第 13 章：附录

Product Code: BMIRE00029603

The North America newborn screening market was valued at US$ 521.55 million in 2022 and is expected to reach US$ 1,082.30 million by 2030; it is estimated to grow at a CAGR of 9.6% from 2022 to 2030.

Surging Government Funding for Newborn Screening Fuels the North America Newborn Screening Market

Governments of different countries are increasingly allocating funds for newborn screening programs. These programs help reduce long-term healthcare costs for children and their parents as congenital and genetic disorders could result in severe health complications and extensive medical interventions if left undetected. By identifying and addressing health issues in infancy, governments can enhance the health and well-being of their citizens. Thus, newborn screening aligns with broader public health objectives to improve overall population health and reduce the burden on healthcare systems.

Government funding promotes equity in healthcare access, ensuring that newborn screening services are available to all, regardless of socioeconomic status. This inclusivity is essential for early disease detection and intervention, as it prevents disparities in healthcare outcomes among different demographic groups. As governments continue to prioritize newborn screening through increased funding and policy support, the newborn screening market has been experiencing sustainable growth worldwide.

North America Newborn Screening Market Overview

The newborn screening market in North America has experienced significant growth in recent years. The demand for newborn screening services has increased significantly with the surging awareness among parents and healthcare professionals about the importance of early screening for identifying and managing congenital disorders. Additionally, improvements in medical technology have been crucial in enhancing newborn screening capabilities-automation in laboratories has boosted screening accuracy, speed, and cost-effectiveness. This has made it possible for medical professionals to give thorough newborn screening panels that cover a larger spectrum of genetic and metabolic disorders. Favorable legislation and regulatory measures also benefit the newborn screening market in North America. Many states and provinces have implemented mandatory newborn screening programs, ensuring all infants are screened shortly after birth. For instance, every state in the US offers newborn screening as a public health program; yearly, ~4 million babies are screened under this program for illnesses that aren't often present at the time of delivery. The Texas Department of Health and Human Services began screening newborn for Spinal Muscular Atrophy (SMA) in June 2021.

The rising prevalence of genetic abnormalities and congenital problems has highlighted the significance of newborn screening. The National Institutes of Health has given a researcher from the University at Buffalo a highly competitive R01 grant to lead an international project developed as an effort to significantly increase the accuracy of newborn screening for three rare, frequently fatal genetic diseases. Further, the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH funds the US$ 3.8 million five-year award. Thus, the newborn screening market in North America is increasing with increased awareness, technological advancements, supportive policies, and growing congenital disorder prevalence.

North America Newborn Screening Market Revenue and Forecast to 2030 (US$ Million)

North America Newborn Screening Market Segmentation

The North America newborn screening market is segmented based on product type, technology, test type, end user, and country.

Based on product type, the North America newborn screening market is bifurcated into reagents and assay kits, and instruments. The reagents and assay kits segment held a larger North America newborn screening market share in 2022. The reagents and assay segment kits is subsegmented into DNA-based assays, and immunoassays and enzymatic assays. Instruments segment is subsegmented into newborn disorder screening instruments, pulse oximeters, newborn hearing screening instruments, and other instruments.

In terms of technology, the North America newborn screening market is categorized into tandem mass spectrometry (TMS), molecular assays, immunoassays and enzymatic assay, pulse oximetry screening technology, and other technologies. The pulse oximetry screening technology segment held the largest North America newborn screening market share in 2022.

Based on test type, the North America newborn screening market is categorized into dry blood spot test, hearing screen test, critical congenital heart diseases (CCHD) test, and other test types. The dry blood spot test segment held the largest North America newborn screening market share in 2022.

By end user, the North America newborn screening market is segmented into hospitals and clinics and diagnostic laboratories. The hospitals and clinics segment held a larger North America newborn screening market share in 2022.

Based on country, the North America newborn screening market is categorized into the US, Canada, and Mexico. The US dominated the North America newborn screening market in 2022.

Baebies Inc, Bio-Rad Laboratories Inc, Masimo Corp, Medtronic Plc, Natus Medical Inc, PerkinElmer Inc, and Waters Corp are some of the leading companies operating in the North America newborn screening market.

Table Of Contents

Table of Content

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Newborn Screening Market - Key Industry Dynamics

  • 4.1 Key Market Drivers
    • 4.1.1 Surging Government Funding for Newborn Screening
    • 4.1.2 Rising Burden of Congenital Diseases
    • 4.1.3 Increasing Prevalence of Newborn Disorders
  • 4.2 Key Market Restraints
    • 4.2.1 Lack of Uniformity in Newborn Screening Policies and Practices
  • 4.3 Key Market Opportunities
    • 4.3.1 Genetic Screening of Newborns
  • 4.4 Future Trends
    • 4.4.1 Integration of Machine Learning and Artificial Intelligence in Screening
  • 4.5 Impact Analysis:

5. Newborn Screening Market - North America Market Analysis

  • 5.1 North America Newborn Screening Market Revenue (US$ Mn), 2022 - 2030

6. North America Newborn Screening Market - Revenue and Forecast to 2030 - by Product Type

  • 6.1 Overview
  • 6.2 North America Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • 6.3 Reagents and Assay Kits
    • 6.3.1 Overview
    • 6.3.2 Reagents and Assay Kits: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 North America Newborn Screening Market, by Reagents and Assay Kits, 2020-2030 (US$ Million)
  • 6.4 Instruments
    • 6.4.1 Overview
    • 6.4.2 Instruments: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.4.2.1 North America Newborn Screening Market, by Instruments, 2020-2030 (US$ Million)

7. North America Newborn Screening Market - Revenue and Forecast to 2030 - by Technology

  • 7.1 Overview
  • 7.2 North America Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • 7.3 Tandem Mass Spectrometry (TMS)
    • 7.3.1 Overview
    • 7.3.2 Tandem Mass Spectrometry (TMS): North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Molecular Assays
    • 7.4.1 Overview
    • 7.4.2 Molecular Assays: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Immunoassays and Enzymatic Assays
    • 7.5.1 Overview
    • 7.5.2 Immunoassays and Enzymatic Assays: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Pulse Oximetry Screening Technology
    • 7.6.1 Overview
    • 7.6.2 Pulse Oximetry Screening Technology: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Other Technologies
    • 7.7.1 Overview
    • 7.7.2 Other Technologies: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Newborn Screening Market - Revenue and Forecast to 2030 - by Test Type

  • 8.1 Overview
  • 8.2 North America Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 8.3 Dry Blood Spot Test
    • 8.3.1 Overview
    • 8.3.2 Dry Blood Spot Test: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Hearing Screen Test
    • 8.4.1 Overview
    • 8.4.2 Hearing Screen Test: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Critical Congenital Heart Diseases (CCHD) Test
    • 8.5.1 Overview
    • 8.5.2 Critical Congenital Heart Diseases (CCHD) Test: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Other Test Types
    • 8.6.1 Overview
    • 8.6.2 Other Test Types: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Newborn Screening Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 North America Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Laboratories
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Laboratories: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Newborn Screening Market - Country Analysis

  • 10.1 North America Newborn Screening Market, Revenue and Forecast To 2030
    • 10.1.1 North America Newborn Screening Market, by Country
      • 10.1.1.1 US
        • 10.1.1.1.1 US Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.1.2 US: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.2.1 US: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.2.2 US: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.1.3 US: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.1.4 US: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.1.5 US: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.2 Canada
        • 10.1.1.2.1 Canada Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.2 Canada: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2.1 Canada: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.2.2 Canada: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.2.3 Canada: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.2.4 Canada: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.2.5 Canada: Newborn Screening Market, by End User, 2020-2030 (US$ Million)
      • 10.1.1.3 Mexico
        • 10.1.1.3.1 Mexico Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.2 Mexico: Newborn Screening Market, by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.2.1 Mexico: Newborn Screening Market, For Reagents and Assay Kits by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.2.2 Mexico: Newborn Screening Market, For Instruments by Product Type, 2020-2030 (US$ Million)
        • 10.1.1.3.3 Mexico: Newborn Screening Market, by Technology, 2020-2030 (US$ Million)
        • 10.1.1.3.4 Mexico: Newborn Screening Market, by Test Type, 2020-2030 (US$ Million)
        • 10.1.1.3.5 Mexico: Newborn Screening Market, by End User, 2020-2030 (US$ Million)

11. North America Newborn Screening Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Newborn Screening Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 PerkinElmer Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Waters Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Bio-Rad Laboratories Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Masimo Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Natus Medical Inc.
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Baebies Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Medtronic Plc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. North America Newborn Screening Market Segmentation
  • Table 2. North America Newborn Screening Market, by Reagents and Assay Kits - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Newborn Screening Market, by Instruments - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. US Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. US Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. US Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Canada Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Canada Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Canada Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Canada Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico Newborn Screening Market, by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Mexico Newborn Screening Market, For Reagents and Assay Kits by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Mexico Newborn Screening Market, For Instruments by Product Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Mexico Newborn Screening Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Mexico Newborn Screening Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Mexico Newborn Screening Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Recent Organic Growth Strategies in Newborn Screening Market
  • Table 23. Recent Inorganic Growth Strategies in the Newborn Screening Market
  • Table 24. Glossary of Terms, Newborn Screening Market

List Of Figures

  • Figure 1. North America Newborn Screening Market Segmentation, By Country
  • Figure 2. North America Newborn Screening Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. North America Newborn Screening Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. North America Newborn Screening Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • Figure 6. Reagents and Assay Kits: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Instruments: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. North America Newborn Screening Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 9. Tandem Mass Spectrometry (TMS): North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Molecular Assays: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Immunoassays and Enzymatic Assays: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Pulse Oximetry Screening Technology: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Other Technologies: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. North America Newborn Screening Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 15. Dry Blood Spot Test: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Hearing Screen Test: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Critical Congenital Heart Diseases (CCHD) Test: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Other Test Types: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. North America Newborn Screening Market Revenue Share, by End User, 2022 & 2030 (%)
  • Figure 20. Hospitals and Clinics: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Diagnostic Laboratories: North America Newborn Screening Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. North America: Newborn Screening Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 23. North America Newborn Screening Market, By Key Countries, 2022 and 2030 (%)
  • Figure 24. US Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Canada Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. Mexico Newborn Screening Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Growth Strategies in Newborn Screening Market